Alpha Cognition is trading 8.4% down at $8.00 as the stock continues to retrace following a sharp multi-day rally driven by enthusiasm for its Alzheimer’s program and bullish analyst sentiment.
- The downward move follows a 7.3% decline on July 30, signaling continued profit-taking after the recent run-up.
- Shares are facing additional pressure from a broader biotech sector pullback, with the XBI ETF dropping over 3% as investors rotate out of higher-risk names.